Indian Oncology Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1211

  • Format: PPT, PDF

Indian Oncology Drugs Market Segmented by Cancer type (Breast Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Ovarian Cancer), by Therapy type (Medical Oncology, Radiation Oncology, Surgical Oncology) and End- User (Hospitals, Clinics) Forecast (2019 – 2028)

SKU: 1211 Categories: ,

Report Overview

Indian Oncology drugs market size stood at USD XX Million in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of 14.6% during the forecast period of 2019-2028.

Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. India is reported the home to 14 lakh cancer patients in 2016.The Indian Government, has taken initiatives to work out public-private partnership projects (PPP) and reduce the essential drug prices. In May 2020, India-based 4baseCare announced to launch targeted oncocare tests at one-fourth of the cost of the existing genetic tests. Oral cancer is a major health problem in India as in most cases it gets detected only in the later stages of the illness resulting in lesser cure options and higher expenses. In India, the cost of genetic tests has come down to USD 4.06 to USD 947.36 from USD 2,706.76 to USD 3,383.45 per test.

Market Drivers

Higher Prevalence and Incidence of Cancer Diseases, unhealthy lifestyle, increasing geriatric population, growth of the industry including, increasing FDI, increase in the number of cancer health insurances. Besides, focus on drug development for the reduction of cancer cases has also increased. Increasing healthcare expenditure of India is also contributing to the market growth. Efforts have been undertaken to develop genomic databases specific to the Indian population. In this regard, the Council of Scientific and Industrial Research (CSIR) launched the IndiGen Genome Project in April 2019 to sequence whole genomes of 1,008 Indians.

1. Oncology Drugs Market Overview…………………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Increased Prevalence of Cancer
B. Increasing Healthcare Expenditure
C. Increasing Geriatric Population
3. Oncology Drugs Type……………………………………………………………………
A. H Immune Checkpoint Inhibitors
I. Nivolumab (Opdivo)
II. Atezolimumab (Tecentriq)
III. Pembrolizumab (Keytruda)
IV. Durvalumab (Imfinzi)
B. Monoclonal Antibodies
I. Rituximab (Rituxan)
II. Trastazumab (Herceptin)
III. Bevacizumab (Avastin)
IV. Nimotuzumab (Biomab EGFR)
V. Pertuzumab (Perjeta)
VI. Ado-Trastuzumab Emtansine (Kadcyla)
C. Cancer Vaccines
I. Gardasil
II. Cervarix
4. Oncology Drug Market Segmentation………………………………………………
A. Cancer Type
I. Breast Cancer
II. Lung Cancer
III. Kidney Cancer
IV. Liver Cancer
V. Ovarian Cancer
B. Therapy Type
I. Medical Oncology
II. Radiation Oncology
III. Surgical Oncology
C. End- User
I. Hospitals
II. Clinics
III. Others
5. Oncology Major Drugs Market Share……………………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Illumina Inc. Company overview, Product & Services, Strategies & Financials
B. Genotypic Technology Company overview, Product & Services, Strategies & Financials
C. MedGenome Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Oncology drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Cancer Type:

Based on cancer type the oncology market is segmented into Breast Cancer, Lung Cancer, Kidney cancer, Liver cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Colorectal, Blood Cancer, others. Lung Cancer is the fastest growing segment by cancer type this is owing to consumption of cigarettes and alcohol.

By Therapy Type:

Based on Therapy type Oncology Market is segmented into Medical Oncology, Radiation Oncology, Surgical Oncology, and others. Medical Oncology is the fastest-growing segment by therapy type and is estimated to grow with CAGR of XX% in India. Medical Oncology is a modality of treatment of cancer care, which uses Chemotherapy, Immunotherapy, Hormonal Therapy, and Targeted Therapy to treat cancer in an effective manner.

By End- User:

Based on End-Users, the market is segmented into hospitals, clinics, and others. The hospitals and clinics segment held the largest share of 34.29% in 2019. With over 1 million new cases of cancer diagnosed in the country each year, the need for NGS-based comprehensive testing continues to increase for accurate and cost-saving testing.

Major Players

The major players of Oncology Device Market are Illumina Inc., Genotypic Technology Pvt. Ltd., Tecan Trading AG, SciGenom Labs Pvt. Ltd., Xcelris Labs Ltd, Eurofins Scientific, 4baseCare, MedGenome, Sayre Therapeutics, Redcliffe Lifesciences, Partek Incorporated, Bio-Rad Laboratories, Myriad Genetics, Hologic, Inc. (Gen-Probe Incorporated), Horizon Discovery Group plc, Vela Diagnostics, Premas Life Sciences Pvt. Ltd. (PLS). MedGenome Labs Ltd. is one of the largest private-sector genomic solutions providers in India. It provides genomic tests in oncology, inherited diseases, reproductive health, and infectious diseases and performed more than 1, 20,000 tests in 2019. Premas Life Sciences Pvt. Ltd. Is another top leading company of oncology device market in India. It provides AmpliSeq for SARS-COV-2 Research Panel, manufactured by Illumina, for epidemiological research on the SARS-COV-2 virus in India. Beside this, researchers from Tata Centre for Technology and Design, IIT Bombay are currently working on developing indigenous CAR (chimeric antigen receptor) T-cell therapy, affordable for cancer patients in India.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements